
### [NCIT:C66745](http://purl.obolibrary.org/obo/NCIT_C66745)
**Label:** Adenocarcinoma with Neuroendocrine Differentiation

**Subclasses:** [NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation), [NCIT:C127915](http://purl.obolibrary.org/obo/NCIT_C127915) (Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.00%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39197](http://purl.obolibrary.org/obo/NCIT_C39197) (PPAR-alpha Gene Regulation Pathway))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39194](http://purl.obolibrary.org/obo/NCIT_C39194) (Phospholipase C Signaling Pathway))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39184](http://purl.obolibrary.org/obo/NCIT_C39184) (PDGF Signaling Pathway))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39168](http://purl.obolibrary.org/obo/NCIT_C39168) (NO2-Dependent IL12 Pathway))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39167](http://purl.obolibrary.org/obo/NCIT_C39167) (Nitric Oxide Pathway))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39164](http://purl.obolibrary.org/obo/NCIT_C39164) (Nerve Growth Factor Pathway))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39162](http://purl.obolibrary.org/obo/NCIT_C39162) (NFAT Pathway))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39152](http://purl.obolibrary.org/obo/NCIT_C39152) (Hepatocyte Growth Factor Receptor Signaling Pathway BioCarta))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39147](http://purl.obolibrary.org/obo/NCIT_C39147) (Calpain-2 Cell Motility Pathway))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39146](http://purl.obolibrary.org/obo/NCIT_C39146) (MAPKinase Signaling Pathway))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39141](http://purl.obolibrary.org/obo/NCIT_C39141) (Longevity Pathway))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39135](http://purl.obolibrary.org/obo/NCIT_C39135) (Keratinocyte Differentiation Pathway))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39130](http://purl.obolibrary.org/obo/NCIT_C39130) (Insulin Signaling Pathway))) 38.93%


